Literature DB >> 17981699

Cerebral vasoconstriction after subarachnoid hemorrhage--role of changes in vascular receptor phenotype.

Jacob Hansen-Schwartz1, Saema Ansar, Lars Edvinsson.   

Abstract

The pathological constriction of cerebral arteries known as cerebral vasospasm (CVS) is with a delay of 4 to 10 days linked to subarachnoid hemorrhage. Several agents have been suggested as being responsible; amongst these perhaps 5-hydroxytryptamine (5-HT) and endothelin-1 (ET-1) are the most prominent given their ability to elicit powerful constriction of cerebral arteries. Investigating both 5-HT and ET receptors we have observed that there are distinct changes in receptor phenotype after experimental SAH, namely upregulation of the ETB and 5-HT1B receptors, and that this upregulation is linked to a higher sensitivity to the endogenous agonists. It has also been shown that reduction in regional cerebral blood flow (CBF) is associated with receptor upregulation and interventional animal experiments have shown a benefit from inhibiting the PKC and MAP kinase pathways on receptor upregulation, CBF and neurological outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981699     DOI: 10.2741/2831

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries.

Authors:  Ahmed F El-Yazbi; Rosalyn P Johnson; Emma J Walsh; Kosuke Takeya; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

2.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

3.  Brainstem opioidergic system is involved in early response to experimental SAH.

Authors:  Justin S Cetas; Robin McFarlane; Kassi Kronfeld; Phoebe Smitasin; Jesse J Liu; Jeffrey S Raskin
Journal:  Transl Stroke Res       Date:  2014-11-25       Impact factor: 6.829

4.  Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.

Authors:  Robert P Ostrowski; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-09-01       Impact factor: 6.829

5.  Inhibition of cerebral vasoconstriction by dantrolene and nimodipine.

Authors:  Salvatore Salomone; Guray Soydan; Michael A Moskowitz; John Randall Sims
Journal:  Neurocrit Care       Date:  2008-10-16       Impact factor: 3.210

6.  A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Authors:  Tomas Garzon-Muvdi; Gustavo Pradilla; Jacob J Ruzevick; Matthew Bender; Lindsay Edwards; Rachel Grossman; Ming Zhao; Michelle A Rudek; Gregory Riggins; Andrew Levy; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2013-10       Impact factor: 4.654

7.  Valproic acid attenuates intercellular adhesion molecule-1 and E-selectin through a chemokine ligand 5 dependent mechanism and subarachnoid hemorrhage induced vasospasm in a rat model.

Authors:  Chih-Zen Chang; Shu-Chuan Wu; Chih-Lung Lin; Aij-Lie Kwan
Journal:  J Inflamm (Lond)       Date:  2015-04-02       Impact factor: 4.981

8.  Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage.

Authors:  Patrick K K Yeung; Jiangang Shen; Stephen S M Chung; Sookja K Chung
Journal:  BMC Neurosci       Date:  2013-10-25       Impact factor: 3.288

9.  Upregulation of 5-hydroxytryptamine receptor signaling in coronary arteries after organ culture.

Authors:  Chun-Yu Deng; Hui Yang; Su-Juan Kuang; Fang Rao; Yu-Mei Xue; Zhi-Ling Zhou; Xiao-Ying Liu; Zhi-Xin Shan; Xiao-Hong Li; Qiu-Xiong Lin; Shu-Lin Wu; Xi-Yong Yu
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.